Full Text View
Tabular View
No Study Results Posted
Related Studies
Methylphenidate in Treating Patients With Melanoma
This study has been completed.
Study NCT00003266   Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999   Last Updated: August 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Fatigue
More general conditions related to this trial
Signs and Symptoms
Interventions listed in this trial
methylphenidate hydrochloride
quality-of-life assessment
Additional drug interventions recognized in this trial
Methylphenidate
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services